Purchase Order HHSN272201700634P
Award Date
5/9/17
Potential Completion Date
6/30/17
Potential Value
$5.5K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Lakepharma, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belmont, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lakepharma, Inc. for $21,769.00 in testing services. The contract has no set-aside designation and was completed on July 3, 2015. Lakepharma, Inc. is a Contract Development and Manufacturing Organization (CDMO) that provides pharmaceutical and biotech services, including affinity maturation, production of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,799.00 firm-fixed-price purchase order contract to Lakepharma, Inc., a minority-owned, for-profit, Asian-Pacific American-owned business, for the cloning and sequencing of mouse hybridoma. The contract has a completion date of September 29, 2017 and was awarded on August 2, 2017. Lakepharma, Inc. is a Contract Development and Manufacturing Organization...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Lakepharma, Inc., a minority-owned, for-profit Contract Development and Manufacturing Organization (CDMO). The $12,999 contract is for DNA scale-up services sufficient for 0.5L production to support the agency's medical research and healthcare mission. The contract has no set-aside designation and was awarded on September 2, 2020 with an...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,499 firm fixed price purchase order to Lakepharma, Inc., a minority-owned, for-profit Contract Development and Manufacturing Organization (CDMO). The award is for monoclonal antibody production and Zika research services. Lakepharma has previously provided similar services to other federal agencies such as the Department of Veterans Affairs and the National Institutes of Health. This award does not have a set-aside...
This is a $599,999.40 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp. The contract is for the development of EAP-derived monoclonal antibodies for phenotyping immune cells of animal models of disease. This work supports infectious disease research and response programs. The contract does not have a...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Pacific Immunology, a for-profit biotech company in Ramona, California. The contract is for monospecific antibody production services, with a ceiling value of $19,297.50 and a period of performance ending on September 30, 2025. The contract does not have a set-aside designation. Pacific Immunology is the prime...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Pacific Immunology, a U.S. biotech company located in Ramona, California. The $4,436.81 contract is for the production and delivery of monospecific antibodies and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH, and does not utilize a small business set-aside. The services to...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $10,580.00 firm fixed-price purchase order to Lofstrand Labs LTD, a for-profit limited liability company, for antibody production and purification services. The contract does not have a set-aside designation and has an ultimate completion date of May 26, 2017. Lofstrand Labs LTD is the prime contractor, and no subcontractors are mentioned. The award is not associated with a larger contract vehicle...